Vericel (VCEL) Operating Expenses (2010 - 2026)
Vericel (VCEL) posted Operating Expenses of $56.0 million for Q2 2026, down 2.38% sequentially from $57.3 million in Q1 2026, and up 15.06% YoY from $48.6 million in Q2 2025.
Vericel (VCEL) Operating Expenses (2010 - 2026) Analysis & Trends
Vericel has reported Operating Expenses for 17 years, with the latest figure at $56.0 million in Q2 2026.
- Quarterly Operating Expenses rose 15.06% year-over-year to $56.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $210.1 million (up 15.56% YoY) and the FY2025 annual result came in at $194.6 million, up 16.09% from the prior year.
- Operating Expenses eased to $56.0 million in Q2 2026 per VCEL's latest filing, from $57.3 million in the prior quarter.
- Over five years, Operating Expenses peaked at $57.3 million in Q1 2026 and troughed at $30.7 million in Q1 2022.
- A 5-year average of $41.4 million and a median of $40.4 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses climbed 4.23% in 2022, then advanced 26.72% in 2025.
- Over 5 years, Operating Expenses stood at $32.2 million in 2022, then climbed by 11.23% to $35.8 million in 2023, then gained by 11.86% to $40.0 million in 2024, then advanced by 26.72% to $50.7 million in 2025, then gained by 10.36% to $56.0 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $56.0 million, $57.3 million, and $50.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Vericel | 2.26 Bn | 2.10 Bn | 56.40 Mn | 55.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 55.97 Mn |
| Mar 31, 2026 | 57.33 Mn |
| Dec 31, 2025 | 50.71 Mn |
| Sep 30, 2025 | 46.14 Mn |
| Jun 30, 2025 | 48.64 Mn |
| Mar 31, 2025 | 49.07 Mn |
| Dec 31, 2024 | 40.02 Mn |
| Sep 30, 2024 | 44.12 Mn |
| Jun 30, 2024 | 42.63 Mn |
| Mar 31, 2024 | 40.82 Mn |
| Dec 31, 2023 | 35.78 Mn |
| Sep 30, 2023 | 35.67 Mn |
| Jun 30, 2023 | 35.90 Mn |
| Mar 31, 2023 | 34.70 Mn |
| Dec 31, 2022 | 32.16 Mn |
| Sep 30, 2022 | 32.02 Mn |
| Jun 30, 2022 | 31.94 Mn |
| Mar 31, 2022 | 30.73 Mn |
| Dec 31, 2021 | 29.89 Mn |
| Sep 30, 2021 | 27.06 Mn |